David Katz
Pediatrics · Wake Forest, NCNPI 1184794166
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Corium, LLC at 48.8% of the total. Reporting peaked in 2021 at $102 and has fallen 79.6% since, to $21 in 2024.
Across 5 payments — averaging $41.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$102
- Phadia US Inc.$43
- Supernus Pharmaceuticals, Inc.$27
- Valneva USA, Inc.$21
- VBI Vaccine (delaware) Inc.$16
Across 5 payments — averaging $134,067 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$670K
What the payments were for
- Food & beverage$208100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 1 | $102 |
| Phadia US Inc. | 1 | $43 |
| Supernus Pharmaceuticals, Inc. | 1 | $27 |
| Valneva USA, Inc. | 1 | $21 |
| VBI Vaccine (delaware) Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Azstarys$102
How this compares
$208 in reported general payments places this provider in the 55th percentile of 1,818 pediatrics providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atovaquone-Proguanil HclAtovaquone/Proguanil Hcl | 160 | $11,721 |
| Yf-VaxYellow Fever Vaccine Live/Pf | 31 | $10,275 |
| IxiaroJapanese Encephalitis Vacc/Pf | 16 | $8,140 |
| IxchiqChikungunya Vaccine, Live/Pf | 14 | $7,760 |
| TwinrixHepatitis A And B Vaccine/Pf | 22 | $7,550 |
| Typhim ViTyphoid Vi Polysacch Vaccine | 26 | $5,275 |
| VaqtaHepatitis A Virus Vaccine/Pf | 12 | $2,405 |
| IpolPoliomyelitis Vaccine, Killed | 22 | $2,240 |
| Azithromycin | 130 | $442 |
| Ciprofloxacin Hcl | 35 | $158 |
| Acetazolamide | 14 | $106 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Valneva USA, Inc.Ixiaro, Ixchiq | $21 | $15,90030 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,818 pediatrics providers in North Carolina.
Other pediatrics in Wake Forest
- James PooleWake Forest$7K
- Dwight KoeberlDurham$8.4M
- Priya KishnaniDurham$5.8M
- James AndersonHigh Point$669K
- Joseph MuenzerChapel Hill$237K
- Ifeyinwa OsunkwoCharlotte$218K
- Edward SmithDurham$164K
- Katherine SmithRaleigh$133K
- James StillRaleigh$105K
- Richard BrugmanGastonia$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.